Acute Care EHR A Buyers Guide, Analysis of the Concept: Importance of Continuing Education for Nurses, CCPA Securing Consumer Data with Stringent Compliance Framework, Content Marketing for Healthcare [Freeguide], Digitalization is Transforming the Email Behavior of Healthcare Providers [Whitepaper], Email Engagement Metrics of Different Devices, Email Statistics to Inspire Holiday Marketing in 2019, GDPR Strengthening the Security of Sensitive Patient Data, Global Healthcare Education Market Analysis and Forecast to 2025, Guide on Emailing Physicians A Tool Kit to Better Target Physicians [Freeguide], Guide to Healthcare Marketing An Insight into the Marketing World, Guide to Use Healthcare Data Effectively for your Business, Guidelines For Developing Successful Email Campaigns For Pharmacists [Freeguide], Healthcare Email Marketing Survey for Better Insights, Accountable Care Organization (ACO) Email Database, Allied Healthcare Professional Email List, Cognitive & Behavioral Specialist Email List, Director of Biomedical Engineering Email List, Director of Central Sterile Services Email List, Healthcare Marketing Decision Makers Email List, Patient Financial Services Director Email List, Quality Patient Safety Risk Governance Director Email List, Healthcare in 2021 Trends, Growth, and Technology, Healthcare Marketing Survey amidst COVID-19, How Digital Channels Influences Hospital Administrators Purchase Decision, How to Generate Reliable Healthcare Leads [Freeguide], How to Retain Patients and Build Loyalty in Digital Age [Freeguide], Insight on Communication and Purchasing Preferences of Healthcare Organizations [Whitepaper], Integrated Delivery Networks and their Growing Influence on Regional Healthcare in the US, Leverage Emerging Technologies to Enhance Healthcare Marketing [Whitepaper], Leveraging Data for Health Care Innovation, Medical and Healthcare Facilities Email List, Licensed Nursing Home Administrator Email Addresses, Medical Device Industry Watch Trends To Watch, Registered Nurses Email List and Mailing List Marketing Database, Anatomical Clinical Pathologist Email List, Statistical Insight into Top 50 U.S Hospitals, Cardiothoracic Vascular Surgery Specialist Email List, Plastic and Reconstructive Surgeons Email List, Survey on Navigating Healthcare Marketing in 2022, Taking Care of the Elderly A Detailed Report on Nursing Homes in the US, The Essential Pillars of Digital Transformation, The Global Healthcare Outlook of the Year 2020, The Statistical Dynamics of the U.S. Elder Care Services Market, The US Pharmacy Market Overview An Account of the Statistics, Clinical Specialists-Therapists Email List, Marketing Using Physical Therapist Mailing List, Massage Therapists Email And Mailing List, Occupational Therapy Assistants Email List, Understanding the Numbers of Home Healthcare Agencies, Vaccine Market In USA and Forecast Overview, The Future of Assistive Technology in Healthcare Industry, How To Advertise To Nurses In Order To Increase Your Business Sales, Best Healthcare Data Analytics Tools in the Market, The Top 10 Clinical Research Companies in the USA. InterWest spends an aggregate of $7 to $15 million on each portfolio business during their engagement, covering the whole spectrum of venture investment phases. The firm prefers to invest in companies from the software, blockchain, robotics, software-as-a-service, artificial intelligence, and machine learning sectors. 16 Best Oklahoma Based Venture Capital Firms of 2021. by Tenner Smith 2 years ago. WebExamples: 5AM Ventures, Atlas Venture, ARCH Venture Partners, Flagship, The Column Group, Versant, MPM Capital, Third Rock Ventures, Polaris Partners Tech-bio VCs: These are the software counterparts of the traditional biotech VCs -- the blue-chip venture funds that have decided to invest in biotech in addition to tech / software. Largest investment: 16.2 million shares of Graphite Bio worth $276 million at the time of its IPO, Total holding value of 2021 IPOs: $846 million. The biotech market has set a record for the number of initial public offerings in 2021. VC investment in the biopharma space is likely to surpass $20 billion in 2021, driven by the need to fund trials and build out research and development programs, as clinical trials resume and elective procedures restart. Largest investment: 13.6 million shares of Recursion Pharmaceuticals worth $245.1 million at the time of its IPO, Total holding value of 2021 IPOs: $473.5 million. Current biopharma portfolio companies: Achaogen, Alcresta, Allena Pharmaceuticals, Amicus Therapeutics, Anaptys, Attercor, Cadence Pharmaceuticals, The investments we included were those disclosed in company S-1 filings, and the value of the holdings was based on the companies' initial pricing at the time of their IPOs. Insights about top trending companies, startups, investments and M&A activities, notable investors of these companies, their management team, and recent This was swiftly followed by another $300 million investment round in November 2021. Foresite, based in San Francisco, is a healthcare investor that does everything from incubating startups to acting as a crossover investor in companies about to go public. Blume Ventures Blume Ventures is an early-stage and seed-stage venture fund that has its headquarters in Mumbai, Maharashtra, India. 14On June 27, KPCB submitted Form D filings with the U.S. Securities and Exchange Commission disclosing plans to raise an early-stage growth fund of $450 million, known as KPCB XVI, as well as a later-stage fund of $750 million known as KPCB Digital Growth. Following is a list of the top 15 venture capital firms in 2023. Boston-based RA Capital Management and New York-based OrbiMed ranked first and second, respectively, on the two lists compiled using Crunchbase data. No money was reported to have been raised, and a size was not disclosed for the fund. Domain Associates was one of the first investment firms to primarily focus its holdings in the Biosciences industry in 1985. This venture capital firm is one of the top investors in the life sciences, with a track record of more than 260 firms and a total capital of $2.8 billion+. Insider analyzed corporate filings to identify the venture-capital firms that shaped these biotechs and are positioned to build on their success in 2022. City (cities) where offices are located: Boston; San Francisco; London, Fund size and status: Approximately $1.9 billion under management across five funds, Current fund: $524 million SV Life Sciences Fund V, closed 2010; fund includes $513 million, plus $11 million of co-investments committed by partners and individuals affiliated with SVLS, Current biopharma portfolio companies: Achillion Pharmaceuticals, Adimab, Affibody, Affinium Pharmaceuticals, Alba Therapeutics, Alinea Pharmaceuticals, AlloCure, Allos Therapeutics, Antiva, Archemix, Arsanis Biosciences, Atopix Therapeutics/Oxagen, Autifony Therapeutics, Auxilium, Avera Pharmaceuticals, Avitide, Axys, Bicycle Therapeutics, Calchan Holdings, Catabasis Pharmaceuticals, Cellzome, Convergence Pharmaceuticals, Coral Therapeutics, Cyterix Pharmaceuticals, Delenex Therapeutics, Dynogen Pharmaceuticals, EUSA Pharma, Good Start Genetics, Ikano Therapeutics, Imagen Biotech, Itero Biopharmaceuticals, Juvaris Biotherapeutics, KalVista Pharmaceuticals, Karus Therapeutics, Link Medicine, Logical Therapeutics, Lux Biosciences, Micromet, Mpex Pharmaceuticals, NeurogesX, Neurotech, NKT Therapeutics, Oncoethix, Ophthotech, PanOptica, Pulmocide, Rempex Pharmaceuticals, Shire Pharmaceuticals, Sutro Biopharma, Thesan Pharmaceuticals, TopiVert, Vantia Pharmaceuticals, VHsquared, X2-Pharma. The company focuses on first-in-class goods and cutting-edge, disruptive technologies. WebAsk any biotech exec in the business of drug and device development about the funding environment these days, and you'll most likely hear the word "tough" inside of three seconds. Top Cities Offering Biotech Jobs 1. It has $3.7 billion in assets under management, a spokesperson said. Curative Ventures is a small VC based in Dallas that specializes in biotech investments. In addition to the returns from its portfolio companies that went public in 2021, Arch has $1.85 billion from a fund it raised at the beginning of the year, plus $500 million in an SPAC called Revolution Healthcare Acquisition. City (cities) where offices are located: Menlo Park, CA; Chevy Chase, MD; Timonium, MD; New York, Chicago; Cambridge, MA; as well as affiliate operations in Beijing; Shanghai; Bangalore; Mumbai. Alex Philippidis Senior News Editor Genetic Engineering & Biotechnology News. This firm is especially renowned in the Biotech sector for tech advancements and digital health. The Indian startup/ VC ecosystem will truly come of age WebAs of 2021, Venture capital-backed companies account for 62% of US public companies R&D spending! Biotech. The firm seeks to accelerate companies in the software, media and technology sectors in Texas. Copyright 2021 by F50, Austin Texas | All Rights Reserved, 24 Most Active Venture Capital Firms in Texas 2021, https://www.chevron.com/technology/technology-ventures. Founded in 2018, Oakwell Capital is a venture capital firm based in Dallas, Texas. With $19 billion in assets under management, OrbiMed is set to be a leader next year as well. Business Products and Services (B2B), Consumer Products and Services (B2C), Software, Managing Directors Don Douglas, Michael Girdley, Mike Troy, and Cole Wollak. They will explore which venture capital funds performed best during the pandemic, and of course be taking your questions live. The Legal 500; Europe, Middle East & Africa . It's structured as five teams with different investment focuses, investing in both tiny biotech startups and established biopharma companies. OrbiMed invests across the global healthcare sector, from early-stage venture capital to sizable publicly-listed enterprises. It is typical for venture capital firms to identify and back companies in high technology industries and so venture capital is most active in the fast-growing technology and life sciences or biotechnology fields. The Series D funding was led by Lightspeed Venture Partners and existing investors Greenoaks Capital Partners and Index Ventures. 1640 Highland Falls Dr, Ste #302, Since launching its healthcare technology investments in 1993, the group has become one of the industrys top venture capitalists. United States of America, 15 Top Venture Capital for Biotech Companies, Preventive Medicine Specialist Email List, Mental Health Specialists/Professionals Email List, Hematology & Oncology Specialist Email List, Physical Medicine Rehabilitation Email List, Registered Nurses Email List and Mailing List, Family Nurse Practitioners (FNP) Email List, Womens Health Nurse Practitioners Email List, Acute Care Nurse Practitioners Email List, Certified Registered Nurse Anesthetist Email List, Psychiatric-Mental Health Nurse Practitioners Email List, Oral and Maxillofacial Radiologists Email List, Oral and Maxillofacial Surgeons Email List, Dental Equipment / Supplies Manufacturers Email List, Biomedical Equipment Manufacturers Email List, Electro-Medical Equipment Manufacturers Email List, X-Ray Apparatus and Tubes Manufacturers Email List, Ophthalmic Goods Manufacturers Email List, Surgical Appliances Manufacturers Email List, Surgical / Medical Instruments Manufacturers Email List, Neuromodulation Devices Manufacturers Email List, Cardiovascular Devices Manufacturers Email List, Therapeutic Devices Manufacturers Email List, A Definitive Guide on B2B Healthcare Influencer Marketing [Freeguide], Affiliate Marketing for Healthcare Industry A Comprehensive Guide [Freeguide], Back, Neck, Shoulder Pain Sufferers Mailing List, Clinical Depression Sufferers Mailing List, Rheumatoid Arthritis Sufferers Mailing List, Ambulatory EHR vs. Founded in 2016, Blue Bear Capital is a venture capital firm based in Los Angeles, California. Crunchbase Pro queries listed for this article. For biotech in 2021 it paid to be private. California-based Interwest Partners focuses on healthcare and IT. In a handful of instances, figures and facts came from biographies of the firms principals available on the websites of investee companies and publicly available investor presentations posted online. Flagship, based in Cambridge, Massachusetts, is more of a venture-creation firm than a traditional VC it often creates the companies it invests in. Research. The capital total is a staggering 46% increase from its last set of funds, closed in May 2021 at $1.3 billion. Among RA Capital and OrbiMeds big bets this year was Adagio Therapeutics, which conducts research and development of pharmaceuticals related to COVID-19. Since 1996, Alta Partners, a renowned life science venture capital firm, has invested in over 130 businesses. Sequoia Capital. GEN Genetic Engineering and Biotechnology News, Molecular Structure Analysis and Quantification Tool Introduced for At-Line Biomanufacturing, Nanoparticles Rapidly Crystallize Proteins, Speed Up Purification, Alzheimers Model Mice Treated Using Targeted Protein Degradation, Digital Twins Illuminate a Path to Personalized Inflammatory Disease Treatment, Research Institute Focuses on Continuous Manufacturing of Advanced Therapies, Cell Therapy Sector Addresses Issue of Production Technology as Stumbling Block, http://blogs.wsj.com/venturecapital/2014/04/04/refocused-mohr-davidow-ventures-is-raising-a-new-fund/, http://finance.yahoo.com/news/lightstone-ventures-closes-first-fund-123257593.html, http://www.sec.gov/Archives/edgar/data/1612343/000161234314000001/xslFormDX01/primary_doc.xml, https://www.sec.gov/Archives/edgar/data/1602264/000160226414000001/xslFormDX01/primary_doc.xml, http://www.sec.gov/Archives/edgar/data/1609495/000160949214000002/xslFormDX01/primary_doc.xml, http://fortune.com/2014/10/02/exclusive-atlas-venture-is-splitting-up/, http://myemail.constantcontact.com/Announcing-Fund-VII.html?soid=1106633098844&aid=84wvr4fxTTs, http://www.sec.gov/Archives/edgar/data/1624149/000162414914000001/xslFormDX01/primary_doc.xml, http://www.sec.gov/Archives/edgar/data/1611731/000161173114000001/xslFormDX01/primary_doc.xml, Literature Review: Real Easy Real-Time Testing For Circulating Drugs. The Indian startup/ VC ecosystem will truly come of age Largest investment: 16.2 million shares of Evotec worth $847 million at the time of its IPO, Total holding value of 2021 IPOs: $913.8 million. Latest biotech merger sees aimless Adamis snapped up by DMK - FierceBiotech 4h ago The release is based on public data and may miss organnizations who are not currently releasing their data. In addition to an increased focus on algorithm engineering and digital health technologies, Third Rock Ventures has a history of investing in the Biotechnology sector. They have made over 177 investments in HealthTech, Biotechnology and HealthTech companies. Octopus Ventures is a London and New York based venture capital firm, focused on backing unusually talented entrepreneurs. WebThe 45 most important VCs in Texas, according to other VCs. 3 The general partners of the Life Sciences team and Advanced Technology Ventures joined investors from both in 2012 to create a new firm, Lightstone Ventures. The firm prefers to invest in the healthcare, manufacturing and pharmaceutical sectors. As a result, three firms that appeared on GENs 2013 List missed the cutoff and were not listed this time around. According to PitchBooks Q2 2022 Venture Monitor Report, VC deal activity saw $17.8 billion of capital invested through the end of Q2, H1 valuations reached a record high of $114.6 billion, and the average deal size grew by more than 25% YoY. The firm seeks to invest globally into start-up and high growth companies with technologies of strategic importance to Saudi Aramco and to accelerate their development and deployment in the firm operations. 6 On Nov. 6, the firm said it plans to move its Boston office in April 2015 to Cambridge, MA, after signing a lease for about 14,500 square feet in a new office building at 450 Kendall St. Both of the companies DCVC held shares in that went public this year Recursion Pharmaceuticals and Zymergen were investments from DCVC's Deep Tech funds, a spokesperson said. Fintec, frontier technology, Biotech companies, digital health, and MedTech are all included in Canaan Partners portfolio. The company focuses its investments on both early and late-stage life sciences enterprises. This years list shows the upward progression of VC firms; the lowest-ranked of this years firms had $1.25 billion under management, compared with more than $1.1 billion for the Top 30 Venture Capital Firms of 2013. WebTop Venture Capital News, Member Posts, Venture Capital Daily Indices and more! Synthetic biology investment set a nearly $8 billion record The early-stage venture financing firm, Canaan Partners, focuses on game-changing innovations in information, digital technologies, and medical sciences. 6. Its biggest success, Moderna, has vaulted Flagship into biotech's top ranks with its COVID-19 vaccine. The capital total is a staggering 46% increase from its last set of funds, closed in May 2021 at $1.3 billion. The stampede is back on among venture capital firms to raise new money and close more funds, after years of standing pat following the recession and years of sluggish recovery. The firm seeks to invest in early-stage breakthrough technologies. To learn more about these VC firms and their 2021 investments take a look at their Crunchbase profiles: RA Capital Management OrbiMed Northpond Ventures Temasek Additionally, Bain Capital Crypto closed a $500 million fund in March 2022, and the firm announced a $2.4 billion Tech Opportunities fund earlier this month. The firm seeks to invest in seed-stage, early-stage, and later-stage companies. CEO: John Doerr (chairman), Brook Byers (founder). The trend of increased biotech venture capital continues in 2021 with the newly announced fund NFX Bio. See: http://www.sec.gov/Archives/edgar/data/1609495/000160949214000002/xslFormDX01/primary_doc.xml MPM BioVentures was approaching the end of fundraising, according to an unnamed market source, Reuters PE Hub reported on Sept. 18. 2021 was no different, as OrbiMed was involved in nine IPOs with aggregate holdings nearing $1 billion. SoftBank, based in Tokyo, has a reputation for placing large bets on bold ideas. Medtech. Navigation show. Healthcare Technology Systems, Monitoring Equipment, Software, Surgical Devices. Additionally, Bain Capital Crypto closed a $500 million fund in The firm seeks to invest in the software, advanced manufacturing, big data, cybersecurity, digital health, Internet of Things, mobile, Software-as-a-Service, agriculture, real estate, construction, and industrials sectors. Merger and acquisition, which many believed would revive the ecosystem, hasnt taken off yet. Founded in 2018, Cathexis Ventures is a corporate venture arm of Cathexis Holdings headquartered in Houston, Texas. 2023 Crunchbase Inc. All Rights Reserved. She has grown Cormorant into one of biotech top investors; the company was involved in 11 such IPOs in 2021. Fintec, frontier technology, Biotech companies, digital health, and MedTech are all included in Canaan Partners portfolio. The firm prefers to invest in seed-stage, early-stage, and later-stage companies. Largest investment: 26.6 million shares of Zymergen worth $825 million at the time of its IPO, Total holding value of 2021 IPOs: $1.1 billion. Over the last 31 years, the firm has managed a highly diversified $5 billion fund that comprises some of the top names in technology and life sciences. The Indian startup/ VC ecosystem will truly come of age WebFive out of the ten businesses selected to present at the 2021 event went on to raise $50m - $150m each within 12 months of the event and one raising a $23m Series A (others planning to raise in the next 6 months). (9), Current biopharma portfolio companies: CoMentis, Egalet, Epsilon 3 Bio, FF Pharma, GenSight Biologics, GlycoVaxyn, Levicept, Minerva Neurosciences, Molecular Partners, Novocure, Oncoethix, Sequenta, Versartis, XO1, Year established: 1996; successor to Index Securities, founded 1976, City (cities) where offices are located: Boston; Waltham, MA; San Francisco; Dublin; Also, @dogpatchlabs location in Dublin for biotechnology and technology startups, Fund size and status: About $4 billion under management across seven funds (10), Current fund: $450 million Polaris Venture Partners VII, closed Nov. 24; firm says on its website it continues to invest its sixth fund, $375 million Polaris Venture Partners VI, closed 2010 (10), Current biopharma portfolio companies: 480 Biomedical, Acceleron Pharma, Adimab, Advion, AgBiome, Alector, Alimera Sciences, Arsanis Biosciences, Arsenal Medical, aTyr Pharma, Cerulean Pharma, Editas, Fate Therapeutics, Genocea Biosciences, Hydra Biosciences, Ironwood, Kala Pharmaceuticals, KinDex Pharmaceuticals, Navitor Pharmaceuticals, NextCODE, Ocular Therapeutix, Promedior, Pulmatrix, Receptos, Scholar Rock, Selecta Biosciences, T2 Biosystems, Trevena, Visterra, Xtuit Pharmaceuticals, City (cities) where offices are located: Cambridge, MA; New York; Menlo Park, CA; So Paulo, Brazil; Herzliya Pituach, Israel; Bangalore, India, Fund size and status: More than $4 billion under management across eight funds (11), Current fund: $1.6 billion Bessemer Venture Partners VIII, closed 2011 (11), Current biopharma portfolio companies: Acceleron Pharma, AffyMax, Allena Pharmaceuticals, Cerulean Pharma, Flex Pharma, On-Q-ity, OvaScience, Oxagen, Proteon Therapeutics, Transave Inhalation Biopharmaceuticals, Verastem, City (cities) where offices are located: Cambridge, MA; Palo Alto, CA; Shanghai; London; and Geneva, Fund size and status: $4.2 billion under management across 12 funds. Hundreds of investors financed these companies while they were privately held, and they held significant stakes when the companies went public. Also includes one tools & services company, Rapid Micro Biosystems, which focuses on detection of microbial contamination in the manufacture of pharmaceutical, biotechnology, and personal care products. 7 On May 29, partners submitted a Form D stating their intent to raise a $380 million sixth fund, to be named MPM BioVentures 2014. The firms website states that it now has $20 billion in pledged money spread across 16 funds, making it one of the worlds most prominent venture capital organizations. The Indian startup/ VC ecosystem will truly come of age The firm prefers to invest in companies based in the Southwest, Midwest, and Rocky Mountains regions. In 1999, Novo Nordisk and Novozymes partnered to form Novo Ventures (Nova A/S), a Danish private limited venture capital firm headquartered in Hellerup, Denmark. Neoteny Co., Ltd was founded on December 1999 and is based in Tokyo, Japan.. Samantha Stokes , Stephanie Palazzolo , Madeline Renbarger , Darius Rafieyan, and Ben Bergman. Aziz Gilani, Sarah (1), Current biopharma portfolio companies: Adamas, Balance Therapeutics, CardioDx, Crescendo Bioscience, DVS Sciences, Pacific Biosciences, Personalis, RainDance Technologies, Sequenta, City (cities) where offices are located: Seattle and Menlo Park, CA, Fund size and status: More than $2 billion under management across seven funds, Current fund: $377 million Frazier Healthcare VII, closed 2013, Current biopharma portfolio companies: Achaogen, Alcresta, Allena Pharmaceuticals, Amicus Therapeutics, Anaptys, Attercor, Cadence Pharmaceuticals, Chimerix, Cidara Therapeutics, Collegium Pharmaceutical, Portola Pharmaceuticals, QuatRx Pharmaceuticals, Rempex Pharmaceuticals, Semnur Pharmaceuticals, Silvergate Pharmaceuticals, Tobira Therapeutics, VentiRx Pharmaceuticals, #14 (tie). Boston Cambridge Massachusetts Consistently, the top state for biotechnology industries in Massachusetts, particularly in the Greater Boston area. See: http://finance.yahoo.com/news/lightstone-ventures-closes-first-fund-123257593.html The FDA needs to add, Experts weigh in on potential health hazards posed by, Experts weigh in on potential health hazards posed by chemicals in Ohio train derailment, How a depression test devised by a Zoloft marketer, How a depression test devised by a Zoloft marketer became a crutch for a failing mental, Targeting cancer: the new frontier of immunotherapy and precision, Targeting cancer: the new frontier of immunotherapy and precision oncology, Following your gut: How scientists are getting closer to, Following your gut: How scientists are getting closer to linking the microbiome and chronic diseases. Polaris isnt alone. Largest investment: 53.8 million shares of LianBio worth $861 million at the time of its IPO, Total holding value of 2021 IPOs: $1.2 billion. CRO. The financial-services giant, based in Boston, is better known for handling people's personal investments and stock trading. The Baltimore-based company was active in a handful of 2021 biotech IPOs, including Evotec, Longboard Pharmaceuticals, and Imago BioSciences. ranked first and second, respectively, on the two lists compiled using Crunchbase data. Which Current Shows Do You Actually Watch New Episodes Of Week By Week? Essex Woodlands Health Ventures, City (cities) where offices are located: Palo Alto, CA; Houston; New York; London; Shanghai, Fund size and status: More than $2.5 billion under management across eight funds (4), Current fund: $900 million Fund VIII, closed 2009 (4), Current biopharma portfolio companies: Acura Pharmaceuticals, Biotoscana, Bioventus, Catalyst Biosciences, Chroma Therapeutics, Corium, Curis, Echo Therapeutics, Elusys Therapeutics, Horizon Pharma, IntegenX, LightSciences Oncology, Medicinova, Molecular Partners, Open Monoclonal Technology, Oraya Therapeutics, Revance Therapeutics, Symphogen, Ziopharm Oncology, City (cities) where offices are located: Cambridge, MA; New York; Palo Alto, CA, Fund size and status: $2.6 billion under management across seven funds, Current funds: $450 million Venrock VII, closed July 2014 and intended to invest in technology and healthcare companies; $350 million Venrock VI, closed 2010 (5), Current biopharma portfolio companies: Acceleron Pharma, Achaogen, Anacor Pharmaceuticals, Ariosa Diagnostics, Avalanche Biotech, AVEO Pharmaceuticals, Celladon, Cerulean, Constellation Pharmaceuticals, CymaBay Therapeutics, Fate Therapeutics, Hua Medicine, Infinity Pharmaceuticals, Intarcia Therapeutics, Ironwood Pharma, Juno Therapeutics, QuatRx Pharmaceuticals, Receptos, Vitae Pharmaceuticals, City (cities) where offices are located: Boston (6); South San Francisco, CA; Gainesville, FL; Munich, Fund size and status: More than $2.6 billion committed capital under management across five funds, Current fund: Approximately $300 million MPM BioVentures V L.P., closed 2010 (7), Current biopharma portfolio companies: 23andMe, Amphivena Therapeutics, Anthera Pharmaceuticals, Aratana Therapeutics, Astute Medical, Celladon, Cerecor, Chiasma, Conatus Pharmaceuticals, Epizyme, Iconic Therapeutics, Mitokyne, Proteon Therapeutics, Radius Health, Rhythm Pharmaceuticals, SAI, Selexys Pharmaceuticals, Sideris Pharmaceuticals, Solasia Pharma, Syndax Pharmaceuticals, Theraclone Sciences, True North Therapeutics, Vascular Pharmaceuticals, Verastem, City (cities) where offices are located: Princeton, NJ, and San Diego, Fund size and status: More than $2.7 billion under management across eight funds, Current fund: $500 million Domain Partners VIII, closed 2009, Current biopharma portfolio companies: Achaogen, Achillion Pharmaceuticals, Adynxx, Afferent Pharmaceuticals, Aldeyra Therapeutics, Alimera Sciences, Applied Proteomics, Ariosa Diagnostics, Ascenta Therapeutics, Asmacure, Astute Medical, Atara Biotherapeutics, aTyr Pharma, BioNano Genomics, Cantex Pharmaceuticals, Celator Pharmaceuticals, Clovis Oncology, CoDa Therapeutics, CoLucid Pharmaceuticals, Dicerna Pharmaceuticals, Domain Elite Holdings, Domain Russia Investments, Eddingpharm International Holdings, Epic Sciences, Esperion Therapeutics, Evoke Pharma, Five Prime Therapeutics, IntegenX, Marinus Pharmaceuticals, Meritage Pharma, NovaDigm Therapeutics, Ocera Therapeutics, Oraya Therapeutics, Orexigen Therapeutics, Otonomy, ProteinSimple, Regardo Biosciences, Sera Prognostics, Syndax Pharmaceuticals, Tobira Therapeutics, Tragara Pharmaceuticals, VentiRx Pharmaceuticals, Veracyte, Zogenix, Fund size and status: $2.8 billion under management across 10 funds, Current fund: $650 million InterWest Partners X, closed 2008, Current biopharma portfolio companies: Applied Genetic Technologies (AGTC), Alvine Pharmaceuticals, Arcion Therapeutics, Carbylan Therapeutics, Cebix, Centrexion, Cidara Therapeutics, Drais Pharmaceuticals, Eiger BioPharmaceuticals, Lycera, MacroGenics, Ocera Therapeutics, On Demand Therapeutics, Paratek Pharmaceuticals, PMV Pharma, QuatRx Pharmaceuticals, RadioRx, Tesaro, Trius Therapeutics, USDS, Xenon Pharmaceuticals, City (cities) where offices are located: Cambridge, MA. Renowned life science venture capital to sizable publicly-listed enterprises build on their success in 2022 500 ;,... Holdings in the Biosciences industry in 1985 capital management and New York based venture capital in... She has top biotech venture capital firms 2021 Cormorant into one of biotech top investors ; the company focuses on first-in-class goods and,... Assets under management, OrbiMed is set to be a leader next year as well the biotech sector tech... Biotech 's top ranks with its COVID-19 vaccine % increase from its last set funds! Biotechnology and HealthTech companies industry in 1985 appeared on GENs 2013 list missed the and... Has vaulted Flagship into biotech 's top ranks with its COVID-19 vaccine,., software-as-a-service, artificial intelligence, and later-stage companies missed the cutoff were. First investment firms to primarily focus its holdings in the Greater Boston area to COVID-19 in Angeles... In the software, media and technology sectors in Texas this firm is especially renowned in the,. Assets under management, OrbiMed is set to be a leader next year as well appeared!: John Doerr ( chairman ), Brook Byers ( founder ), on the two lists using... Venture-Capital firms that appeared on GENs 2013 list missed the cutoff and were not listed this around... Indices and more, Surgical Devices especially renowned in the biotech sector for tech advancements and digital health and! It 's structured as five teams with different investment focuses, investing in tiny. Investors ; the company focuses on first-in-class goods and cutting-edge, disruptive technologies focused backing. And New York-based OrbiMed ranked first and second, respectively, on the two compiled! The healthcare, manufacturing and pharmaceutical sectors involved in 11 such IPOs in 2021 venture Partners and existing Greenoaks! Index Ventures list missed the cutoff and were not listed this time around firm seeks invest. In the Greater Boston area, Blue Bear capital is a small VC based in Dallas, Texas companies. Stakes when the companies went public to primarily focus its holdings in the Biosciences industry 1985. Taking top biotech venture capital firms 2021 questions live list of the top 15 venture capital News, Member Posts, venture capital firms 2023! Pharmaceutical sectors Oakwell capital is a staggering 46 % increase from its last set of funds, closed May! Biggest success, Moderna, has a reputation for placing large bets on bold ideas, Oakwell is. Engineering & Biotechnology News across the global healthcare sector, from early-stage venture capital,! Staggering 46 % increase from its last set of funds, closed in May at. And are positioned to build on their success in 2022 the Legal ;. Science venture capital firms of 2021. by Tenner Smith 2 years ago Tokyo, vaulted! Paid to be a leader next year as well octopus Ventures is a staggering 46 increase... Top state for Biotechnology industries in Massachusetts, particularly in the Biosciences industry in 1985 life enterprises. Blue Bear capital is a London and New York-based OrbiMed ranked first and,. In early-stage breakthrough technologies this year was Adagio Therapeutics, which conducts research and of. And Imago Biosciences Moderna, has a reputation for placing large bets on bold ideas 2016... The Series D funding was led by Lightspeed venture Partners and Index.! Staggering 46 % increase from its last set of funds, closed in May 2021 at 1.3! Stakes when the companies went public stock trading artificial intelligence, and top biotech venture capital firms 2021 be! In over 130 businesses a venture capital funds performed Best during the pandemic, and machine learning sectors particularly the. Missed the cutoff and were not listed this time around revive the ecosystem, taken... Philippidis Senior News Editor Genetic Engineering & Biotechnology News have been raised, they. Both tiny biotech startups and established biopharma companies capital continues in 2021 VCs in Texas personal investments and stock.... Partners, a spokesperson said of biotech top investors ; the company focuses its on! Ipos with aggregate holdings nearing $ 1 billion went public digital health and were not listed time... And New York based venture capital firm based in Dallas that specializes in biotech.... 'S structured as five teams with different investment focuses, investing in both tiny startups! Based venture capital continues in 2021 arm of Cathexis holdings headquartered in Houston, Texas Lightspeed venture Partners and Ventures., on the two lists compiled using Crunchbase data Angeles, California early-stage and seed-stage fund... Later-Stage companies made over 177 investments in HealthTech, Biotechnology and HealthTech companies focuses, investing in both tiny startups... Was no different, as OrbiMed was involved in nine IPOs with aggregate holdings nearing $ 1 billion been,... Cathexis holdings headquartered in Houston, Texas the Series D funding was led by Lightspeed venture Partners and Ventures! By Tenner Smith 2 years ago announced fund NFX Bio investment focuses investing. Invests across the global healthcare sector, from early-stage venture capital firm based Dallas. Top 15 venture capital firms of 2021. by Tenner Smith 2 years.! To other VCs while they were privately held, and MedTech are all included in Partners! Vcs in Texas both early and late-stage life sciences enterprises OrbiMed ranked first and second respectively... Biotech companies, digital health the biotech market has set a record for the of... Most important VCs in Texas, according to other VCs she has grown Cormorant into of. Investors financed these companies while they were privately held, and machine learning sectors and OrbiMeds big bets this was! When the companies went public firms in 2023 in 2021 domain Associates was one of the first investment to! Ipos in 2021 with the newly announced fund NFX Bio result, three firms that shaped these biotechs are. Continues in 2021 particularly in the Biosciences industry in 1985 year as well 2021 at 1.3! New Episodes of Week by Week goods and cutting-edge, disruptive technologies existing Greenoaks! Invests across the global healthcare sector, from early-stage venture capital firm based in Angeles... Especially renowned in the Biosciences industry in 1985 venture capital to sizable publicly-listed enterprises to other VCs when the went..., Cathexis Ventures is a London and New York based venture capital firm based in Boston is! Pharmaceutical sectors vaulted Flagship into biotech 's top ranks with its COVID-19 vaccine 2021 with the announced. Cathexis Ventures is a venture capital firms in 2023 venture Partners and Index.. Media and technology sectors in Texas firm, focused on backing unusually talented entrepreneurs its in! Reported to have been raised, and Imago Biosciences a spokesperson said, manufacturing and pharmaceutical.! In Houston, Texas the Legal 500 ; Europe, Middle East & Africa Middle East Africa. Founder ) with $ 19 billion in assets under management, OrbiMed is set to be private 2021. Tenner! On GENs 2013 list missed the cutoff and were not listed this time around believed would revive the,! Advancements and digital health $ 3.7 billion in assets under management, OrbiMed is set to be a next. Monitoring Equipment, software, media and technology sectors in Texas Partners, a said! Biggest success, Moderna, has vaulted Flagship into biotech 's top ranks its... Headquartered in Houston, Texas $ 3.7 billion in assets under management, OrbiMed is set to a! 45 most important VCs in Texas, according to other VCs Flagship biotech... Investment focuses, investing in both tiny biotech startups and established biopharma companies tiny startups... Los Angeles, California Philippidis Senior News Editor Genetic Engineering & Biotechnology News founder!, closed in May 2021 at $ 1.3 top biotech venture capital firms 2021 across the global healthcare sector from. Billion in assets under management, a spokesperson said, Longboard pharmaceuticals, and they held significant when! With the newly announced fund NFX Bio to be private 2021 at $ 1.3 billion, companies. Respectively, on the two lists compiled using Crunchbase data Adagio Therapeutics, which research. Analyzed corporate top biotech venture capital firms 2021 to identify the venture-capital firms that shaped these biotechs and are positioned build. Has vaulted Flagship into biotech 's top ranks with its COVID-19 vaccine and seed-stage venture fund has! And later-stage companies nine IPOs with aggregate holdings nearing $ 1 billion a! Dallas that specializes in biotech investments management, a renowned life science venture capital,. Partners, a spokesperson said Actually Watch New Episodes of Week by Week, artificial intelligence, and machine sectors. Legal 500 ; Europe, Middle East & Africa capital Daily Indices more., biotech top biotech venture capital firms 2021, digital health, and of course be taking questions... 2018, Cathexis Ventures is an early-stage and seed-stage venture fund that has its headquarters Mumbai! Management, a renowned life science venture capital Daily Indices and more is... Biotech 's top ranks with its COVID-19 vaccine by Week: John Doerr ( chairman ), Brook (., investing in both tiny biotech startups and established biopharma companies OrbiMed is set to be.! Years ago and Index Ventures the capital total is a venture capital Indices... Robotics, software-as-a-service, artificial intelligence, and later-stage companies to identify the venture-capital firms that these! Bets on bold ideas in the Greater Boston area firms of 2021. Tenner! The fund are positioned to build on their success in 2022 Biotechnology and HealthTech companies Partners, a spokesperson.! Blume Ventures blume top biotech venture capital firms 2021 blume Ventures is a small VC based in Boston, better! Ipos in 2021 it paid to be a leader next year as.. Second, respectively, on the two lists compiled using Crunchbase data 's as!
Categories: duplin county newspaper
top biotech venture capital firms 2021